摘要
1型糖尿病(T1DM)是由致病性T淋巴细胞介导的以胰岛B细胞进行性破坏为特征的自身免疫性疾病。自身反应性T淋巴细胞破坏胰岛p细胞,使得存在于胰岛细胞内的自身抗原释放,被B淋巴细胞识别,从而产生抗体。
出处
《广东医学》
CAS
CSCD
北大核心
2012年第18期2703-2705,共3页
Guangdong Medical Journal
参考文献19
-
1KAWASAKI E, KURIYA G, SATOH T, et al. Humeral immune response to islet autoantigens in Japanese patients with type 1 dia- betes[J]. Ann N Y Acad Sci, 2008, 1150:248 -251.
-
2BARJER J M, MCFANN K K, ORBAN T. Effect of oral insulin on insulin autoantibody levels in the Diabetes Prevention Trial Type 1 oral insulin study [ J]. Diabetologia, 2007, 50 (8): 1603 - 1606.
-
3DEVENDRA D, GALLOWAY T S, HORTON S J, et al. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes [ J ]. Diabetologia, 2003,46 ( 6 ) : 802 - 809.
-
4BINGLEY P J, BONIFACIO E, MUELLER P W. Diabetes Anti- body Standardization Program: first assay proficiency evaluation [J]. Diabetes, 2003, 52(5): 1128-1136.
-
5CHIMIENTI F, DEVERGNAS S, PATTOU F, et al. In vivo ex- pression and functional characterization of the zinc transporter ZnT8 in glucose- induced insulin secretion [ J ]. J Cell Sci, 2006, 119 (Pt 20) : 4199 -4206.
-
6SLADEK R, ROCHELEU G, RUNG J, et al. A genome - wide association study identifies novel risk loci for type 2 diabetes [ J ]. Nature, 2007, 445(7130) : 881 -885.
-
7WENZLAU J M, WALTER M, GARDNER T J, et al. Kinetics of the post - onset decline in zinc transporter $ autoantibodies in type 1 diabetic human subjects [ J ]. J Clin Endocrinol Metab, 2010, 95(10) : 4712 -4719.
-
8BINGLEY P J, GALE E A. Progression to type 1 diabetes in islet cell antibody - positive relatives in the European Nicotinamide Dia- betes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk [ J ]. Diabetologia, 2006, 49 ( 5 ) : 881 - 890.
-
9ZIEGLER A G, HUMMEL M, SCHENKER M, et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes : The 2 - year analysis of the German BABYDIAB study[J]. Diabetes, 1999, 48(3) : 460 -468.
-
10GARDNER S G, GALE E A, WILLIAMS A J, et al. Progression to diabetes in relatives with islet autoantibodies, Is it inevitable? [ J]. Diabetes Care, 1999, 22 (12) : 2049 - 2054.
同被引文献43
-
1Grossi A, Palma A, Fierabracci A, et al. Muhiorgan autoimmunity in a Turner syndrome patient with partial monosomy 2q and trisomy 10p[ J]. Gene, 2013,515:439-443.
-
2Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: American Thyroid Association management guidelines of the and American Association of Clinical Endocrinologists[ J]. Endoer Pract,2011,17 :456-520.
-
3Pihoker C, Gilliam LK, Hampe CS, et al. Autoantibodies in diabetes [ J ]. Diabetes,2005,54 Suppl2 : S52-61.
-
4Wenzlan JM, Walter M, Gardner TJ, et al. Kinetics of the post- onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects [ J]. J Clin Endocrinol Metab, 2010, 95: 4712-4719.
-
5Ziegler AG, Rewers M, Simell O, et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children [ J]. JAMA,2013,309:2473-2479.
-
6Pescovitz MD, Greenbaum C J, Krause-Steinrauf H, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function[J]. N Engl J Med,2009,361:2143-2152.
-
7Jorgensen KT, Rostgaard K, Bache I, et al. Autoimmune diseases in women with Turner' s syndrome [ J ]. Arthritis Rheum, 2010, 62:658-666.
-
8Mortensen KH, Cleemann L, Hjerrild BE, et al. Increased prevalence of autoimmunity in Turner syndrome--influence of age [ J]. Clin Exp Immunol,2009 ,156 :205-210.
-
9Lleo A, Moroni L, Caliari L, et al. Autoimmunity and Turner's syndrome[ J]. Autoimmun Rev, 2012,11 : A538-543.
-
10Bakalov VK, Gutin L, Cheng CM, et al. Autoimmune disorders in women with turner syndrome and women with karyo typically normal primary ovarian insufficiency[J]. J Autoimmun,2012,38: 315-321.
引证文献6
-
1陈阳,杨涛,范红旗.Turner综合征合并1型糖尿病一例及文献复习[J].中华糖尿病杂志,2014,6(4):260-262. 被引量:1
-
2李晓珍,黄秀红,郑华才.胰岛自身抗体检测在糖尿病分型诊断的价值[J].中国实用医刊,2015,42(19):98-99. 被引量:1
-
3李彦青,董自杰,孙晓慧,赵鸿斌.T1DM患者直系亲属ZnT-8A、IA-2A、IAA、GADA、ICA检测及3年发病风险分析[J].实用临床医药杂志,2017,21(17):26-30. 被引量:2
-
4李彦青,董自杰,孙晓慧,赵鸿斌.糖尿病自身抗体GADA、IA-2A、ICA、IAA、ZnT-8A对T1DM发病风险的预测价值[J].贵州医药,2018,42(1):22-24. 被引量:6
-
5袁凤易,李生中,刘莉,徐丹,徐平.1型糖尿病胰岛自身抗体阳性率及其与病程的关系[J].广东医学,2018,39(3):368-372. 被引量:4
-
6季荔,石星,倪世宁,刘倩琦,顾威,胡吉,方晨,胡晴芳,徐晶晶,袁翠萍,蔡娅,杨涛.1型糖尿病胰岛自身抗体与年龄和病程的关系[J].南京医科大学学报(自然科学版),2015,35(8):1110-1113. 被引量:1
二级引证文献15
-
1李晨曦,章秋.低促性腺激素性性腺功能减退症合并1型糖尿病及桥本甲状腺炎1例报告并文献复习[J].中国实用内科杂志,2015,35(10):882-884. 被引量:3
-
2夏月平.1型糖尿病自身抗体研究进展[J].糖尿病新世界,2016,19(5):192-194.
-
3李静军,周林,刘学莲.西格列汀联合二甲双胍治疗Ⅱ型糖尿病的临床疗效观察[J].中国民康医学,2017,29(17):19-20.
-
4赵鸿斌,祁洁,李彦青.锌转运蛋白8抗体阳性的1型糖尿病患者胰岛自身抗体阳性率及生化指标水平[J].广西医学,2018,40(13):1424-1426. 被引量:10
-
5潘海东,刘启亮,郑天鹏.肠道病毒引起胰岛β细胞损伤的分子机制[J].临床与病理杂志,2018,38(7):1562-1566. 被引量:1
-
6刘艺文,余洁,马明磊,平凡,张化冰,李伟,许岭翎,李玉秀.1型糖尿病患者血清胰岛自身抗体阳性率及其与临床指标的相关性[J].中国医刊,2019,54(4):371-375. 被引量:10
-
7余淑芳,孙曙光,李祖芳.ZnT-8A对成人隐匿性免疫性糖尿病诊断价值的初步研究[J].临床和实验医学杂志,2019,18(11):1192-1194. 被引量:2
-
8田海容,周立晶,刘宇,关荣春,程丽华.糖尿病自身抗体GADA、IA-2A、ICA、IAA、ZnT-8A对T1DM发病风险的预测意义[J].国际感染病学(电子版),2018,7(4):159-160.
-
9李金超.1型糖尿病未成年患者血糖控制的影响因素研究[J].医药论坛杂志,2019,40(9):108-110. 被引量:2
-
10周翠红,陈欣.胰岛β细胞自身抗体联合检测对糖尿病分型的诊断价值[J].航空航天医学杂志,2019,30(12):1442-1444. 被引量:4
-
1王俊贤,陈建英.Th17介导炎症反应在动脉粥样硬化中的作用[J].广东医学院学报,2011,29(5):549-551. 被引量:1
-
2覃宁玲,盛德乔.miRNA-375与糖尿病关系的研究进展[J].中国老年学杂志,2016,36(3):716-718. 被引量:4
-
3潘建玲,关秀茹.特发性血小板减少性紫癜共刺激分子表达的研究进展[J].国际免疫学杂志,2007,30(4):248-251.
-
4王玲.免疫细胞及细胞因子在胰岛素依赖型糖尿病致病机理的研究进展[J].国外医学(免疫学分册),1997,20(4):190-192. 被引量:11
-
5覃瑶,黄畅,林圣云.中药治疗再生障碍性贫血作用机制研究进展[J].浙江中西医结合杂志,2016,26(10):970-973. 被引量:4
-
6李煜环,宋振顺.调节性T淋巴细胞与1型糖尿病的关系[J].中华糖尿病杂志,2011,3(1):77-80. 被引量:1
-
7何炯红,杨龙.肺结核患者血清肿瘤坏死因子-α的变化[J].中国医师进修杂志,2004,27(S1):29-30.
-
8李梦豪,卢浩,熊浩伟,刘季晨,郭志刚.以T淋巴细胞为靶点抗动脉粥样硬化的新进展[J].中国循环杂志,2015,30(8):807-810. 被引量:7
-
9赵忠良,吕新法,吴健敏,胡中荣.冻融裂解和蛋白变性剂对肝组织内HBV抗原释放的影响[J].浙江医科大学学报,1993,22(3):115-116.
-
10蓝海峰,杨仁池.特发性血小板减少性紫癜发病机制的认识[J].内科急危重症杂志,2006,12(6):258-261. 被引量:11